<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05042882</url>
  </required_header>
  <id_info>
    <org_study_id>2021-00724</org_study_id>
    <nct_id>NCT05042882</nct_id>
  </id_info>
  <brief_title>Enteral vs. Oral Nutrition After Pancreatoduodenectomy</brief_title>
  <acronym>NUTRIWHI</acronym>
  <official_title>Early Enteral vs. Oral Nutrition After Whipple Procedure: a Multicentric Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne Hospitals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients suffering from pancreas cancer as well as patients with chronic pancreatitis or&#xD;
      requiring pancreas surgery often are in a compromised nutritional status. Nutritional support&#xD;
      should therefore be started early during the postoperative course to prevent further&#xD;
      malnutrition, as it is an important risk factor to develop complications. Recently, several&#xD;
      studies have shown that early enteral nutrition (EEN) could shorten length of stay, reduce&#xD;
      postoperative infections and mortality, and decrease costs when compared with total&#xD;
      parenteral nutrition (TPN) in gastrointestinal cancer surgery. After pancreatoduodenectomy&#xD;
      (PD), EEN has been shown to reduce early and late complications, infections, and readmission&#xD;
      rates. It is nevertheless currently not clear if EEN improves the short-term outcomes after&#xD;
      PD compared to oral nutrition.&#xD;
&#xD;
      The primary objective of the study is to assess the impact of EEN on postoperative morbidity&#xD;
      after PD, according to the Comprehensive Complication Index. Secondary objectives are to&#xD;
      assess the impact of EEN on major postoperative complications, according to Clavien&#xD;
      classification, specific complications, length of stay, readmission rates, quality of life,&#xD;
      metabolic stress and nutritional response after PD.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">January 2025</completion_date>
  <primary_completion_date type="Anticipated">January 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comprehensive Complication Index</measure>
    <time_frame>Postoperative day 90</time_frame>
    <description>Index measuring all complications for a patient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severe postoperative complications</measure>
    <time_frame>Postoperative day 90</time_frame>
    <description>Dindo-Clavien &gt;II</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specific complications after pancreatoduodenectomy</measure>
    <time_frame>Postoperative day 90</time_frame>
    <description>SSI, DGE, POPF, PPH, biliary fistula, gastrojejunal anastomosis fistula, pancreatitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>Up to 90 days</time_frame>
    <description>From operation day to hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission</measure>
    <time_frame>Postoperative day 90</time_frame>
    <description>Hospital readmission due to surgical complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients' quality of life</measure>
    <time_frame>Preoperatively and at 30 and 90 days after the operation</time_frame>
    <description>EORTC questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic response to enteral nutrition</measure>
    <time_frame>Preoperatively and twice weekly during the first postoperative week</time_frame>
    <description>Laboratory results</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Preoperatively and on the day when patients leave the hospital after the operation</time_frame>
    <description>Bioelectrical impedance analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscular measure</measure>
    <time_frame>Preoperatively and on the day when patients leave the hospital after the operation</time_frame>
    <description>Handgrip strength measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting energy expenditure</measure>
    <time_frame>On postoperative day 5</time_frame>
    <description>Indirect calorimetry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Pancreaticoduodenectomy</condition>
  <condition>Malnutrition</condition>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>Early enteral nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention group: enteral nutrition from the first postoperative night until 50% of caloric requirements are covered by oral nutrition. Enteral nutrition will start at a flow of 250 ml/12h. If tolerated, enteral nutrition will be increased to 500 ml/12h on postoperative day 1, 750 ml/12h on postoperative day 2, and 1000 ml/12h on postoperative day 3. A hypercaloric enteral nutrition will be used (Isosource Energy Fibre or similar).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral nutrition</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group: patients will receive standardized oral nutrition. The night after the operation, patients will be allowed to have free drinks. On postoperative day 1, they will receive bouillons, creams, yogurts, and drinks &gt;2 l. On postoperative day 2, they will receive a light diet. On postoperative day 3, they will receive half portion of normal diet and on postoperative day 4 normal diet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Early enteral nutrition</intervention_name>
    <description>Enteral nutrition via nasojejunal tube</description>
    <arm_group_label>Early enteral nutrition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient scheduled for elective open pancreatoduodenectomy.&#xD;
&#xD;
          -  Patient ≥18 years old.&#xD;
&#xD;
          -  Patient at nutritional risk, i.e., with Nutrition Risk Screening (NRS) ≥3.&#xD;
&#xD;
          -  Signed informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient not able to give informed consent as documented by signature of consent form&#xD;
             (e.g., vulnerable patients).&#xD;
&#xD;
          -  Enteral feeding already initiated preoperatively.&#xD;
&#xD;
          -  Language barrier.&#xD;
&#xD;
          -  Inability to follow the procedures of the study, e.g., due to language problems,&#xD;
             psychological disorders (i.e., eating disorders and bipolar disorders), or dementia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gaëtan-Romain Joliat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lausanne University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markus Schäfer, MD</last_name>
    <role>Study Director</role>
    <affiliation>Lausanne University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicolas Demartines, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Lausanne University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gaëtan-Romain Joliat, MD</last_name>
    <phone>+41795564293</phone>
    <email>gaetan.joliat@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Atrium Health Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Dionisios Vrochides</last_name>
    </contact>
    <investigator>
      <last_name>Dionisios Vrochides</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regional Hospital of Lugano</name>
      <address>
        <city>Lugano</city>
        <state>Ticino</state>
        <country>Switzerland</country>
      </address>
    </facility>
    <contact>
      <last_name>Alessandra Cristaudi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Alessandra Cristaudi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pietro Majno-Hurst</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lausanne University Hospital (CHUV)</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <country>Switzerland</country>
      </address>
    </facility>
    <contact>
      <last_name>Gaëtan-Romain Joliat, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gaëtan-Romain Joliat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 30, 2021</study_first_submitted>
  <study_first_submitted_qc>September 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2021</study_first_posted>
  <last_update_submitted>September 6, 2021</last_update_submitted>
  <last_update_submitted_qc>September 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne Hospitals</investigator_affiliation>
    <investigator_full_name>Gaëtan-Romain Joliat</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Enteral nutrition</keyword>
  <keyword>Oral nutrition</keyword>
  <keyword>Pancreatoduodenectomy</keyword>
  <keyword>Whipple operation</keyword>
  <keyword>Pancreas surgery</keyword>
  <keyword>Morbidity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

